Before you use
Lanzap Capsule, discuss with your doctor if you are allergic to it or its ingredients. Your doctor may prescribe an alternative medicine and update your medical records to record this information.
Before you use
Lanzap, tell your doctor of your medical and health history including the following:
liver problems, abnormal functioning of the
liver, patients allergic to Lanzap or similar medicine that decreases stomach acid, stomach, intestine or duodenal
ulcer, low levels of
magnesium in the blood,
phenylalanine build-up in the body (
phenylketonuria), planning to have blood test of Chromogranin A, patients taking
corticosteroids, weak or brittle joint (
osteoporosis), patients taking
digoxin,
itraconazole,
iron salts,
methotrexate, St John´s wort,
ampicillin,
ketoconazole,
rifampicin,
theophylline,
atanazavir,
warfarin,
fluoxamine, methotrexate,
rilpivirine, or
sucralfate, low levels of
vitamin B-12 in your body, or an autoimmune disease (condition in which the body attacks its own organs, causing swelling and loss of function) such as systemic
lupus erythematosus. Using Lanzap in patients with liver problems or abnormal functioning of the liver may increase the exposure of this medicine. Patients with stomach, intestine or duodenal ulcer are at increased risk of stomach ulcer due to the presence of bacteria (Helicobacter pylori) when using Lanzap. Patients allergic to similar medicines that reduce stomach acid may experience skin rash or
pain in joints. Patients with a history of weak or brittle joints (
osteoporosis) are at increased risk of
fracture in the hip, spine or wrist when using Lanzap. Patients with low magnesium levels in the blood may experience
seizures, abnormal or fast heartbeat,
dizziness, muscle weakness,
cramps or muscle aches, nervousness (jitteriness), spasms of the hands and feet, spasm of the voice box when using Lanzap. Using Lanzap with
digoxin, ampicillin esters, ketoconazole,
iron salts may decrease the absorption of these medicines. Using Lanzap with
rifampicin and St John´s wort decreases the absorption of Lanzap. Using Lanzap with
theophylline increase the clearance of theophylline. Using Lanzap with
atazanavir may decrease the effectiveness of atazanavir. Using Lanzap with warfarin may increase the prothrombin time and risk of stomach and intestinal disorders. Using Lanzap with
fluvoxamine may increase the level of Lanzap. The use of sucralfate may decrease the absorption of Lanzap in the blood. The use of Lanzap with methotrexate may increase the level of methotrexate in the blood.
The use of this medicine may change urine parameters (such as
crystal urea, albuminuria,
glycosuria, hematuria). Increase in the levels of crystals in the urine (crystal urea), albumin in urine (albuminuria), glucose in urine (glycosuria), blood in the urine (hematuria) may be observed in patients taking Lanzap therapy.
The use of this medicine may change liver parameters (such as aspartate transaminase (SGOT or AST), alanine transaminase (SGPT or ALT), gamma-glutamyl transferase (GGTP),
creatinine, bilirubin, alkaline phosphatase). Increase in the level of aspartate transaminase (SGOT or AST), alanine transaminase (SGPT or ALT), gamma-glutamyl transferase (GGTP), bilirubin, creatinine, and alkaline phosphatase may be observed in patients taking Lanzap.
The use of Lanzap Capsule may change blood clotting parameter. Using Lanzap with warfarin increases the blood clotting parameter (International Normalized Ratio (INR) and prothrombin time), which may lead to abnormal
bleeding and fatal. Patients should be monitored for the blood clotting parameters.
The use of this medicine may change magnesium. Magnesium levels should be checked before starting the treatment because low levels of magnesium can happen in individuals who take a proton pump inhibitor medicine for at least three months.
The use of Lanzap Capsule may change blood parameters (such as white blood cells (WBC),
globulin, albumin to globulin ratio (A/G ratio), red blood cells (RBC), blood
potassium, blood urea, hemoglobin,
lipid,
cholestrol, electrolytes,
glucocorticoids, Lactate dehydrogenase (LDH),
platelets). Increase or decrease or abnormal levels of white blood cells, increase in potassium, increase in blood urea, decrease in hemoglobin, increase in lipid (
hyperlipemia), increase in cholesterol, increase or decrease electrolyte, increase glucocorticoids, increase in lactate dehydrogenase (LDH), increase or decrease or abnormal platelets levels may be observed in patients taking Lanzap therapy.
Lanzap Capsule can make you feel sleepy. Be careful when using any machinery, driving a vehicle, or doing any other activity that needs you to be fully alert. The consumption of
alcohol with Lanzap Capsule can worsen the sleepiness. Lanzap Capsule may cause rarely
seizures in some people. If you perform any activities where a loss of consciousness may cause harm to you (or others), you should discuss with your doctor.
The use of Lanzap Capsule during
pregnancy should only be when required. There are no sufficient clinical data available in pregnant women. Lanzap should be used during
pregnancy only after considering the
importance of the drug to mother. The use of Lanzap Capsule Lanzap Capsule while
breastfeeding should only be when required. It is unknown whether Lanzap may pass into breast milk which may cause harmful effects in children. A decision to discontinue Lanzap or
breastfeeding should be made after considering the importance of medicine to the mother. It is not known if this medicine is safe for use in women who are conceiving. Consult with your doctor before you use Lanzap Capsule. It is unknown whether Lanzap may harm the unborn baby.
This medicine may cause
bleeding in the stomach. Regular use of tobacco and
alcohol while using this medicine can increase your risk of bleeding. Discuss this aspect with your doctor if you smoke and drink alcohol regularly. This medicine may increase your sensitivity to sunlight. If this happens, use a sunscreen and cover your skin when you are outdoors. Limit your time in the sun. If you get a
sunburn on your skin, consult with your doctor.
Lanzap Capsule may cause increased incidence of
side-effects in older patients. Elderly patients may see an increased risk of
fracture of the hip, fracture of the wrist, and spine fracture.
Using Lanzap for long-term (more than one year) or at high doses may increase the risk of
fracture in the hip, wrist or spine due to the weak or brittle joint (osteoporosis-related fractures) and decrease the level of magnesium in the blood.